Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Polyethylene Glycol 400 stretches back to the heart of 20th century chemical innovation. Early efforts to alter ethylene oxide led researchers down the path to durable, water-soluble polymers. Over the decades, increased pharmaceutical needs for stable, safe excipients pushed PEG 400 to the front of lab benches and manufacturing lines. Researchers recognized its capacity to dissolve both polar and non-polar compounds, so it earned a place in ointments, capsules, and wider medical applications. The transition from industrial-grade material to pharmaceutical-grade required rigorous refinement, but once purity benchmarks rose to the levels expected in the BP, EP, and USP monographs, PEG 400 slotted firmly into nearly every major pharmacopoeia.
PEG 400 is part of a family of polyethers, made by adding ethylene oxide to water, ethylene glycol, or diethylene glycol. With an average molecular weight of around 400 Daltons, this clear, almost syrupy liquid has a slightly sweet taste. Pharmaceutical-grade production takes place under GMP conditions, with lot testing for impurities, residual solvents, and heavy metals. Quality standards under BP, EP, and USP give pharmacists, formulation scientists, and regulators confidence in its identity, purity, and quality for patient care.
PEG 400 presents as a clear, colorless, and nearly odorless viscous liquid. At room temperature, it holds a density of about 1.125 g/cm³ and remains miscible with water and many organic solvents. Viscosity measures about 90-110 centipoise, depending on temperature and batch. It stabilizes pH but resists breakdown across a wide range, giving pharmaceutical developers reliable performance even under tough storage or transport conditions. Hygroscopicity can factor into shelf-life and container choice, since the compound absorbs water from ambient air. Boiling point, at atmospheric pressure, lies well above typical room or body temperatures, giving it some resilience during sterilization and processing.
Pharma-grade PEG 400 bears strict labeling: batch number, expiry date, manufacturer, storage temperature, and monograph compliance must appear clearly. Specifications run deep: identity checks by IR, capped levels for heavy metals, minimum assay percentage, reaction to oxidizing materials, and acceptable appearance all come standard. Each liter produced enters a logbook with QC certificates on hand, since the stakes in medical applications run high. Adherence to BP, EP, and USP monographs sits non-negotiable, meeting expectations for microbial purity, endotoxin control, and physical consistency.
Manufacturing PEG 400 relies on precise chemistry. Ethylene oxide gets introduced to water or another low molecular weight glycol under controlled, catalyzed conditions. Temperature, pressure, and reaction time all play a role in achieving a polymer with the right chain length. Each batch gets purified by distillation and sometimes activated carbon filtering, removing any unreacted monomer or side-product. Advances in process automation and QA streamline consistency and traceability, limiting batch-to-batch variability. Over the years, companies have adopted ‘green chemistry’ approaches to reduce waste and improve energy use, nudging the process toward sustainability.
Chemists find PEG 400 a useful building block. It survives mild acids and bases, staying intact in many formulation environments. Under harsher oxidizers or certain enzymatic conditions, chain-scission can break molecules to smaller fragments. PEGylation—attaching PEG chains to therapeutic proteins or drugs—improves drug solubility, increases half-life, and can suppress immune responses to protein medicines. Modifying either terminus of the PEG 400 chain, or capping one end with functional groups, turns the substance into an active ingredient or a custom excipient built for more specific interaction.
PEG 400 often goes by other names: Polyethylene Oxide 400, Carbowax 400, Macrogol 400, or simply PEG 400. On international shipping manifests and in pharmacopoeia indexes, names can reflect local languages or regulatory differences, but compliance standards remain aligned. On pharmaceutical labeling, the official synonym will reflect the relevant pharmacopeia standard: Macrogol 400 for EP, Polyethylene Glycol 400 for USP/BP, and so on.
In the lab and on the factory line, safety officers enforce classic chemical precautions: gloves, goggles, and good ventilation during handling. Human exposure at therapeutic levels poses little immediate toxicity—PEG 400 has a record of safety in oral, topical, and parenteral drug products. Accidental spills don’t ignite easily, but can make floors slick and hazardous. Wastewater discharge containing PEG 400 has to meet local regulations, since high levels can potentially throw off biological wastewater treatment plants. Ongoing monitoring for impurities like ethylene glycol and diethylene glycol—both far more toxic—runs standard for every pharmaceutical-grade batch.
Hospitals, pharmacies, and drug manufacturers depend on PEG 400. It carries actives in cough syrups, works as a solvent in injectable drugs, and keeps tablets together as a binder. Topical creams rely on its smooth texture and ability to draw water, accelerating healing and soothing irritated skin. Beyond medicine, it turns up in veterinary products, oral care, cosmetics, and as a viscosity modifier in industrial inks. At my own pharmacy, patients using liquid oral medication with water-insoluble actives regularly benefit from formulations built on PEG 400, making what would otherwise be impossible-to-dose actives available for quick symptom relief. For many chronic conditions, patient compliance improves when medications dissolve well and taste less offensive, both of which PEG 400 helps deliver.
Scientists today are pushing PEG 400 into ever-smarter drug delivery systems. In nanoparticle drug carriers and microspheres, PEGylation shields sensitive molecules from immune attack and extends the time they stay active in the bloodstream. Research teams study new conjugates to fine-tune how drugs release over days or hours. PEG derivatives, having slightly modified structures, open doors for better targeting, faster uptake, or slower elimination. Testing focuses not just on performance but also on long-term biocompatibility, since any new use in humans has to assure zero hidden risks over years of use.
Long-term experience with PEG 400 gives a strong safety profile across oral, dermal, and even IV routes. Clinical data, animal studies, and patient reports confirm low acute or chronic toxicity at pharmaceutical doses. Allergic reactions are rare but possible, especially if impurities creep in or patient sensitivity issues arise—robust QC programs keep those cases vanishingly rare. Large-scale environmental studies show rapid dilution and breakdown in aquatic systems, but vigilance remains high, especially as waste concentrations in industrial or hospital settings can occasionally spike. In toxicology labs, teams repeatedly confirm that PEG 400 itself causes far fewer problems than many predecessor solubilizers, such as propylene glycol or dimethyl sulfoxide. Product recalls due to contamination never go unnoticed—investigators track root causes carefully to protect collective public health trust.
The story of PEG 400 isn’t over—future chapters likely unfold at the intersection of green chemistry and next-generation medicine. Regulatory authorities keep demanding even cleaner excipients. Biopharmaceutical companies move toward more targeted therapies, demanding smarter solubilizers, and even AI-driven formulation modeling. Researchers explore bio-based PEG production, cutting environmental impact and moving toward renewable resources. Nanomedicine design will lean even more on PEGs for camouflaging and stabilizing injectable drug carriers, and oral drug bioavailability work continues to find new ways PEG structures push insoluble compounds into patient-friendly medicines. As global standards tighten, PEG 400’s value as a proven, trusted, and well-understood excipient means it will hold a prominent seat at the table well into the next decade.
Polyethylene Glycol 400, often called PEG 400, shows up on countless ingredient lists in everything from tablets to creams. Many people scan past it without thinking about what it does or why it matters. But my years working with pharmacists and reading pharmaceutical labels taught me this—PEG 400 plays an outsized role in the world of medicine, and its importance can’t be overstated.
Walk into any pharmacy, and you’ll find that PEG 400 helps make certain drugs reliable and easy to use. Tablets, liquid medications, and topical ointments often rely on this substance to dissolve active ingredients, help them spread through the body, and give them a shelf life worth talking about. PEG 400 acts as a solvent: it’s a liquid at room temperature, and its chemical structure lets it work well with both water and some oils. Thanks to this trait, medicine makers use it to help medicines mix properly, so patients can trust the dose and feel the benefits as the doctor intended.
I’ve watched the pharmaceutical industry stress about a single letter difference in grade names, and for good reason. PEG 400 BP EP USP Pharma Grade meets some of the strictest standards—from British Pharmacopoeia, European Pharmacopoeia, and the United States Pharmacopeia. This means only the purest versions go into medicine, bringing peace of mind to doctors and families alike. Down the line, every time a patient swallows a liquid medication or rubs on a prescription cream, they’re indirectly relying on this commitment to quality.
My conversations with production staff made clear that PEG 400’s value isn’t limited to mixing ingredients. It also helps control how fast a drug gets released in the body. With PEG 400, medicine makers can design tablets that dissolve quickly, helpful for pain relief or emergency medications, or they can slow things down for longer-acting treatments. PEG 400’s track record gives researchers a versatile tool in their kit.
Anyone who’s downed unpleasant cough syrups as a kid remembers that not all medicine tastes or feels good. PEG 400 helps solve some of those age-old problems. Its mild, neutral taste and gentle texture blunt harsh flavors and make thick syrups or gels feel smoother going down. It’s part of why certain over-the-counter and prescription options are easier to take than others. It surprises people to learn that something so behind-the-scenes could shape user experience, but that’s the value PEG 400 brings.
Every time I talk with healthcare professionals, the question of safety comes up. PEG 400, thanks to decades of research and world-class scrutiny, is widely regarded as safe for pharmaceutical use. When patients ask about it, I point to both the long track record and the careful sourcing, especially in pharma grade. Some rare sensitivities can occur, so pharmacy teams still keep an eye out and always report problems.
Scientists keep exploring better ways to deliver medicine, and PEG 400 keeps showing up as one of their go-to ingredients. Its flexibility, mixability, and safety profile have led to new patches, gels, and even advanced injectable treatments. It’s not a household name, but if you’ve benefited from easy-to-take medication, PEG 400 may have played a role. Thoughtful research and strong regulation will keep making sure that patients get safe, pleasant, and effective therapies for years to come.
Pharmaceuticals aren’t just about the active ingredients. The substances that help them dissolve or get absorbed—called excipients—play a big part in every dose. Polyethylene Glycol 400, or PEG 400, often works behind the scenes in liquid medicines, eye drops, and capsules. Manufacturers choose it mainly for its ability to dissolve substances that water alone can’t handle. Since PEG 400 ends up in many products taken by mouth and applied to the eyes, its safety matters to millions of people every day.
The U.S. Food and Drug Administration (FDA) and the European Medicines Agency both recognize polyethylene glycol as safe for a range of uses, including in food and drugs. These agencies rely on years of animal data and human case studies. Many hospital pharmacists trust PEG 400. It’s listed in the U.S. Pharmacopeia and has a well-established dosing record. That kind of widespread approval doesn’t happen overnight; it grows from decades of scrutiny, review, and, in some cases, tweaks to concentration limits.
Not all chemicals are created equal, and just because something is in our meds doesn’t mean it fits everybody. Some patients, particularly children and people with allergies or kidney problems, have seen rare side effects from drugs using PEG 400 as a carrier. These reactions usually pop up when huge doses get used or when someone has a unique sensitivity. People with a history of severe allergies, especially to certain injectables that use PEG 400, should talk with their doctor first.
Researchers have linked some cases of allergic response to PEGs in injectable drugs and vaccines, but the connection remains rare. For most people, PEG 400 in tablets and eye drops passes through the body with no fanfare, breaking down to simpler compounds and washing out through urine.
Unlike cleaning products or industrial substances, the version of PEG 400 used in pharmaceuticals meets strict purity checks. Contaminants need to be kept at microscopic levels. Drug manufacturers must test every batch for traces of something called ethylene oxide—a chemical that turns PEG from safe to problematic at high concentrations. No one wants to take medicine laced with leftovers from the factory floor.
PEG 400 sticks around mostly because of its long track record and versatility. A few companies look into plant-based alternatives or other polymers for those with sensitivities. Plant oils, sugar-based alcohols, or new “smart” polymers might one day take PEG’s place. But none match its reliability just yet.
For most adults, medicines and eye drops containing PEG 400 reach store shelves only after passing tests that keep risks low. A pharmacist I know double-checks formulas when a patient with allergies picks up a new prescription. That habit exists for a reason: rare doesn’t mean never. If you or your children take meds often, check the labels and ask questions. Patients with chronic kidney disease, especially, get flagged for extra caution. Only a conversation with the prescribing doctor can clear things up.
PEG 400 helps make medicine work and, for decades, has proven itself safe for the vast majority. Science moves forward by building checks into every dose and watching for patterns, and PEG 400 keeps getting those checks.
Polyethylene Glycol 400, known as PEG 400, pops up in my everyday work, whether I’m in a lab or talking with friends in the pharmaceutical field. People use this liquid in all sorts of products—think skin creams, eye drops, and some drug formulations. Safe handling starts with understanding its character. PEG 400 pours like a thick syrup and picks up water from the air. This property can seem minor until it’s time for storage, and the container gains weight or the product changes.
PEG 400 doesn’t like extreme temperatures. It stays stable at typical room conditions, which experts put between 20°C and 25°C. Letting it warm up over 40°C, though, shortens shelf life and brings in the risk of breakdown. Colleagues who have stashed it near radiators or under direct sun have seen the liquid change color—a red flag that the quality dropped. Cold storage won’t help much either. Under 10°C, it thickens, making pouring and mixing a hassle.
Humidity creeps in when storage spaces get stuffy or containers sit open. PEG 400 pulls in water straight from the air. That sounds harmless, but extra water dilutes pharmaceutical solutions and leads to cloudy skin lotions. Sealing up the bottle, with a cap that twists on tight, fixes most of that. Dry, well-ventilated storage rooms keep the liquid as designed for much longer stretches.
You can’t just use any old jug or tank for PEG 400. Glass and stainless steel work well, and thick HDPE plastics do the trick. Thin plastics flex and sometimes leach chemicals into the liquid. One time, a colleague noticed the the product inside a cheap plastic drum smelled off—a sign of contamination. I learned my lesson: clean containers matter as much as the product itself. Routine checks for cracks, leaks, or crusted buildup seal the deal.
Spills tend to happen at the worst moments. PEG 400’s syrupy feel means it spreads easily and gets slippery—more than a few folks in my warehouse have lost their footing on it. Quick cleanup with absorbent pads and soap cuts the risk. Regular training keeps people on their toes, so nobody waits around for a mess to clean itself up. It’s cheaper to fix the habits than fix accidents.
Clear labels make life simpler. Each bottle or drum needs the product name, date received, and expiration date. This way, you know what you’ve got and how long it can serve its intended role, especially if you’re juggling multiple batches. At work, sloppy documentation led to wasted product. Good records save money and mark a line between safe and questionable stock.
Moving PEG 400 around gets tricky on long truck rides or during hot spells. Trucks with temperature control help. Drivers need to watch out for leaks, both for safety and to hold to local rules. I’ve seen shipments arrive sticky and half-empty because someone overlooked cracked drums in transit. Inspections before loading and after delivery save headaches and make the supply chain more reliable.
Safe, clean, and cool storage—those basics don’t just prevent waste. They keep PEG 400 doing its job in everything from hospital IV bags to cosmetics. Training, care, and clean habits protect both workers and end-users. Smart handling starts small but pays out across an entire operation, especially as regulations around quality and safety grow tougher each year.
Polyethylene Glycol 400, better known as PEG 400, plays a surprising but important role in health and daily life. My first real encounter came during college chemistry labs, where we measured its viscosity for a drug delivery experiment. The reason this compound matters boils down to what it offers—purity, stability, and safety. In medicine, not just any chemical qualifies for use with patients. PEG 400 checks strict boxes, set out by BP (British Pharmacopoeia), EP (European Pharmacopoeia), and USP (United States Pharmacopeia), which all demand high standards and traceability.
PEG 400’s main standout feature: purity above 99%. Regular industrial versions tend to carry impurities from leftover processes, but pharma-grade PEG 400 strips those out. This is a must for injectables, skin creams, eye drops, and oral medications, where every foreign particle could trigger reactions or lower shelf life. As someone who takes prescription meds for a chronic illness, trust in the ingredients matters much more than any marketing spin.
PEG 400 flows like a thick but clear syrup, not quite water, not quite oil. The viscosity usually sits between 70 and 90 cSt (centistokes) at room temperature. Drug makers count on this consistency—too thin or too thick, and the medicine won’t mix, apply, or deliver as intended. Its molecular weight hovers around the 380–420 Dalton range, which keeps it gentle on contact with skin and mucous membranes. Big clunky molecules wouldn’t pass as easily through the body’s barriers.
What about toxicity? PEG 400 stands up to scrutiny. Countless studies spell it out: in pharma-grade form, PEG 400 rarely triggers allergies or serious reactions, even at higher doses. The U.S. FDA gives it a green light as both a direct and indirect additive. The World Health Organization lists it as safe for many pharma applications, so long as manufacturing stays clean.
Every batch of pharma PEG 400 comes with a certificate of analysis. That means the manufacturer checked for water content (usually less than 0.5%) and pH values in the neutral range—crucial since acidic or alkaline chemistry would destroy active drug molecules. Heavy metals, ethylene and diethylene glycol residues, color, and clarity all get analyzed before release. Drug manufacturers and pharmacists depend on these reports for patient safety and to comply with the law. It has become standard practice to file and review this paperwork as part of pharmacy audits.
In recent years, drug recalls have sometimes traced back to inconsistencies or hidden contaminants in excipients—a lesson in why reliable sourcing shouldn’t be skipped. Some countries require independent testing, even when buying from certified suppliers. This practice saves lives, and I’ve seen hospital staff refuse product without proof of analysis. A small mistake can have ripple effects, especially for sensitive populations like children or those with immune conditions.
Poor regulation in parts of the world lets sub-standard PEG 400 slip through supply chains. The solution sits with both regulators and industry leaders: regular checks, transparency, and real consequences for corner cutting. Technology offers a way forward too—blockchain tracking and digital certificates could stop fakes and frauds at the border, before they reach dispensaries or patients. Ongoing education for healthcare staff on how to spot a questionable batch could prevent harm before it happens. Patient health relies not just on scientists and manufacturers, but on everyone along the chain sticking to the facts and raising the bar for quality, every time.
Pharmacies and manufacturers take ingredient compatibility seriously because drug performance and safety depend on it. Polyethylene glycol 400, or PEG 400, shows up in a long list of pills, capsules, and topical liquids. If it doesn’t mix well with another excipient, that could spell trouble—clumping powders, hazy solutions, or improper release rates for the active drug. My own stint working in a pharmacy taught me this quickly. Even the smallest mismatch between excipients meant a batch wouldn’t pass quality checks.
PEG 400 acts as a solvent, plasticizer, and wetting agent. It carries water-loving (hydrophilic) and fat-loving (lipophilic) sides, letting it blend into many formulations. Most people hear about PEG in laxatives or skin creams, but it also plays a huge role in keeping tablets stable or improving drug absorption. Chemists like it for a reason—it mixes easily with water, glycerin, ethanol, and propylene glycol. Its low toxicity profile means it’s safe for most uses, confirmed by plenty of research and decades of track record.
Lactose, microcrystalline cellulose, and starch often share space with PEG 400 in solid dosage forms. From my own tests in compounding labs, blends with PEG 400 stay free-flowing and show no signs of unexpected reactions. Even in suspension and emulsions, PEG 400 rarely causes problems when mixed with common stabilizers and thickeners like xanthan gum or HPMC. Pharmaceutical handbooks and FDA resources back this up—very few cases of incompatibility have surfaced in published literature.
Trouble crops up if PEG 400 meets strong oxidizing agents, since these react and break down PEG’s structure. Some preservatives, like sorbic acid, may run into solubility or stability snags in PEG-rich mixtures. Polyvinylpyrrolidone (PVP) and similar polymers sometimes show changes in viscosity when combined with PEG, though these shifts depend on concentrations and physical conditions. These issues don’t rule out PEG 400, they just call for testing before full-scale production. Any reputable drug maker runs compatibility tests during development for this exact reason—nothing gets left to guesswork.
Pharmaceutical teams have a toolkit to spot problems early. They conduct preformulation screening—basically, mixing small amounts of all the excipients, storing them under heat, light, and humidity, then watching for changes. Physical signs—color shifts, phase separation, or settling—appear first if things don’t mesh. Labs also run analytical tests like HPLC or DSC to monitor for subtle chemical changes. Drawing on years at the bench, I remember the frustration of running these tests day after day. Still, the headache up front beats a product recall down the road.
No one wants a drug that fails mid-shelf life or upsets a patient’s stomach due to ingredient interactions. Solid research and careful formulation testing allow us to build safer, more effective medicines. PEG 400, with its long use history, brings flexibility to the table, but never replaces common sense or a solid lab protocol. Quality professionals, regulatory agencies, and pharmacists all keep a close eye on excipient compatibility for just this reason.
As the industry leans toward new active compounds, both synthetic and biological, the need for compatibility studies grows. PEG 400’s story shows that trusted excipients help, but never guarantee a problem-free path. Whether in a home care pharmacy or a giant manufacturing plant, people must keep testing and cross-checking. Safe medicines rely on it.
| Identifiers | |
| CAS Number | 25322-68-3 |
| Pharmacology | |
| ATC code | A06AD15 |
Chengguan District, Lanzhou, Gansu, China
